Female sex and lung cancer risk in two large screening cohorts
- Antonios Charokopos 1, Amanda Leiter 2, Sakshi Dua 3, Juan P de-Torres 4, Grace Mhango 5, Javier J Zulueta 5, Charles Powell 3, Keith M Sigel 5, Alex D Federman 5, Juan P Wisnivesky 6
- 1Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
- 2Department of Endocrinology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 3Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 4Department of Pulmonary, Clinica Universidad de Navarra, Pamplona, Spain.
- 5Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 6Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 0Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Women and men have similar lung cancer risks, challenging previous assumptions. This finding suggests lung cancer screening efforts should equally target both sexes in relevant demographics.
Area Of Science
- Oncology
- Epidemiology
- Public Health
Background
- Epidemiological studies present conflicting data on sex-based lung cancer susceptibility.
- Previous research has not definitively established whether women are more vulnerable to lung cancer than men.
Purpose Of The Study
- To investigate and compare lung cancer incidence rates between men and women across different smoking statuses and pack-year strata.
- To inform lung cancer screening guidelines by clarifying sex-based risk differences.
Main Methods
- Analysis of data from 154,897 participants in the Prostate-Lung-Colon-Ovary (PLCO) trial and 53,452 participants in the National-Lung-Screening-Trial (NLST).
- Calculation of female-to-male lung cancer incidence rate ratios (IRR) using Poisson regression, adjusting for known risk factors.
- Stratification of analyses by smoking status (never-smokers vs. ever-smokers) and pack-years smoked.
Main Results
- Among never-smokers in PLCO, women showed similar lung cancer rates to men (IRR: 1.23).
- For ever-smokers across various pack-year groups in both PLCO and NLST trials, adjusted analyses revealed comparable lung cancer incidence between sexes.
- A notably lower risk was observed in women smoking 100+ pack-years in the PLCO trial (IRR: 0.66).
Conclusions
- In individuals over 55 years old, women exhibit similar lung cancer risk compared to men, irrespective of smoking history.
- Current lung cancer screening strategies, policies, and awareness campaigns should equally consider both men and women within these demographic groups.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

